ISRCTN25142273已完成不适用
Multinational randomised controlled clinical trial of etoricoxib in the treatment of rheumatoid arthritis
Merck & Co Inc (USA)0 个研究点目标入组 891 人开始时间: 2002年5月9日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 891
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Patients with rheumatoid arthritis
- •2. Aged greater than or equal to 18 years
排除标准
- •Does not match inclusion criteria
研究者
相似试验
已完成
不适用
The second intensive Blood Pressure reduction in acute cerebral haemorrhage trial.intracerebral haemorrhageStroke - HaemorrhagicACTRN12608000362392The George Institute for International Health2,800
已完成
不适用
The second intensive blood pressure reduction in acute cerebral haemorrhage trialIntracerebral haemorrhageCirculatory SystemISRCTN73916115ational Health and Medical Research Council (NHMRC) (Australia)2,839
进行中（未招募）
1 期
Randomized clinical trial to compare the treatment of mild acute diverticulitis with or without antibioticsMild acute diverticulitisMedDRA version: 19.0Level: LLTClassification code 10052812Term: Acute diverticulitisSystem Organ Class: 100000004862EUCTR2016-001596-75-ESFundació Parc Taulí
进行中（未招募）
3 期
Light-Touch StudyNeovascular age-related macular degenerationEye DiseasesISRCTN10012824Moorfields Eye Hospital230
尚未招募
1 期
Multi center randomized controlled clinical trial of Xiezhuo Tongluo Formula in the treatment of chronic kidney disease stage 3-4chronic kidney diseaseITMCTR2000003976The First Affiliated Hospital of Guangzhou University of Chinese Medicine